Company: ZURA
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001410578-25-001100
Chunk: 4

Company: Zura Bio Ltd
Filing Date: 2025-05-08
Form: 10-Q
Item: Part I, Item 1F
Chunk 4
---
Item 1. Financial Statements.

Zura Bio Limited

Condensed Consolidated Balance Sheets

(In thousands, except share data)

​​​​​​​​    March 31,     December 31,​​2025​2024​​(unaudited)​​​Assets​​​​​​Current assets ​​​​  Cash and cash equivalents​$ 170,569​$ 176,498Prepaid expenses and other current assets​​ 1,123​​ 2,246Total current assets​​ 171,692​​ 178,744Property and equipment, net​​ 106​​ 91Other assets​​ 698​​ 698Total assets​$ 172,496​$ 179,533​​​​​​​Liabilities, Redeemable Noncontrolling Interest and Shareholders’ Equity​​​​​​Current liabilities​​​​​​Accounts payable and accrued expenses​$ 21,092​$ 19,514Total current liabilities​​ 21,092​​ 19,514Total liabilities​​ 21,092​​ 19,514​​​​​​​Commitments and contingencies (Note 9)​​​​​​​​​​​​​Redeemable noncontrolling interest​​ 11,663​​ 11,663​​​​​​​Shareholders’ Equity​​​​​​Preferred shares, $0.0001 par value, 1,000,000 authorized as of March 31, 2025 and December 31, 2024; no shares issued and outstanding as of March 31 2025 and December 31, 2024​​—​​—Class A Ordinary Shares, $0.0001 par value; 300,000,000 shares authorized as of March 31, 2025 and December 31, 2024; 68,374,998 and 65,297,530 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively​​ 7​​ 7Additional paid-in capital​​ 311,532​​ 302,705Accumulated deficit​​ (173,339)​​ (155,897)Total Zura Bio Limited shareholders’ equity ​​ 138,200​​ 146,815Noncontrolling interest​​ 1,541​​ 1,541Total shareholders’ equity ​​ 139,741​​ 148,356Total liabilities, redeemable noncontrolling interest and shareholders’ equity ​$ 172,496​$ 179,533

​

See accompanying